Cue Biopharma, Inc. (CUE)
NASDAQ: CUE · Real-Time Price · USD
0.8250
+0.0423 (5.40%)
Apr 23, 2025, 4:00 PM EDT - Market closed
Cue Biopharma Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
| Cash & Equivalents | 22.46 | 48.51 | 51.61 | 64.37 | 74.87 | Upgrade
|
| Short-Term Investments | 0.93 | 0.29 | 24.68 | - | 10 | Upgrade
|
| Cash & Short-Term Investments | 23.39 | 48.8 | 76.29 | 64.37 | 84.87 | Upgrade
|
| Cash Growth | -52.08% | -36.03% | 18.52% | -24.15% | 42.85% | Upgrade
|
| Receivables | 0.95 | 1.7 | 0.06 | 3.14 | 1.42 | Upgrade
|
| Prepaid Expenses | 0.81 | 0.96 | 0.84 | 0.87 | 1.24 | Upgrade
|
| Other Current Assets | - | - | - | 0.08 | - | Upgrade
|
| Total Current Assets | 25.14 | 51.45 | 77.19 | 68.47 | 87.53 | Upgrade
|
| Property, Plant & Equipment | 4.84 | 7.12 | 10.7 | 11.92 | 8.88 | Upgrade
|
| Other Long-Term Assets | 2.21 | 2.96 | 3.39 | 3.01 | 3.12 | Upgrade
|
| Total Assets | 32.19 | 61.53 | 91.28 | 83.4 | 99.53 | Upgrade
|
| Accounts Payable | 2.82 | 3.5 | 2.73 | 2.59 | 2.07 | Upgrade
|
| Accrued Expenses | 2.91 | 4.14 | 3.55 | 4.62 | 2.79 | Upgrade
|
| Current Portion of Long-Term Debt | 4.33 | 3.96 | 1.96 | - | - | Upgrade
|
| Current Portion of Leases | 3.54 | 3.37 | 3.3 | 4.93 | 4.78 | Upgrade
|
| Current Unearned Revenue | 0.09 | 2.11 | - | 0.65 | 6.68 | Upgrade
|
| Other Current Liabilities | - | - | - | 0 | - | Upgrade
|
| Total Current Liabilities | 13.69 | 17.08 | 11.55 | 12.79 | 16.32 | Upgrade
|
| Long-Term Debt | - | 4.2 | 8.04 | - | - | Upgrade
|
| Long-Term Leases | 1 | 3.16 | 6.02 | 5.12 | 2.37 | Upgrade
|
| Long-Term Unearned Revenue | - | - | - | - | 1.94 | Upgrade
|
| Total Liabilities | 14.69 | 24.45 | 25.6 | 17.91 | 20.62 | Upgrade
|
| Common Stock | 0.06 | 0.05 | 0.04 | 0.03 | 0.03 | Upgrade
|
| Additional Paid-In Capital | 359.3 | 338.23 | 316.19 | 262.91 | 232.16 | Upgrade
|
| Retained Earnings | -341.86 | -301.19 | -250.46 | -197.45 | -153.29 | Upgrade
|
| Comprehensive Income & Other | - | - | -0.1 | - | 0.01 | Upgrade
|
| Shareholders' Equity | 17.5 | 37.09 | 65.68 | 65.49 | 78.91 | Upgrade
|
| Total Liabilities & Equity | 32.19 | 61.53 | 91.28 | 83.4 | 99.53 | Upgrade
|
| Total Debt | 8.88 | 14.7 | 19.32 | 10.05 | 7.15 | Upgrade
|
| Net Cash (Debt) | 14.51 | 34.11 | 56.97 | 54.32 | 77.72 | Upgrade
|
| Net Cash Growth | -57.45% | -40.14% | 4.89% | -30.11% | 44.97% | Upgrade
|
| Net Cash Per Share | 0.26 | 0.75 | 1.60 | 1.74 | 2.71 | Upgrade
|
| Filing Date Shares Outstanding | 61.82 | 48.64 | 43.17 | 33.01 | 30.46 | Upgrade
|
| Total Common Shares Outstanding | 61.82 | 47.22 | 43.04 | 32.2 | 30.35 | Upgrade
|
| Working Capital | 11.45 | 34.37 | 65.64 | 55.68 | 71.21 | Upgrade
|
| Book Value Per Share | 0.28 | 0.79 | 1.53 | 2.03 | 2.60 | Upgrade
|
| Tangible Book Value | 17.5 | 37.09 | 65.68 | 65.49 | 78.91 | Upgrade
|
| Tangible Book Value Per Share | 0.28 | 0.79 | 1.53 | 2.03 | 2.60 | Upgrade
|
| Machinery | 4.03 | 4.29 | 5.62 | 5.55 | 4.51 | Upgrade
|
| Construction In Progress | - | - | - | - | 0.41 | Upgrade
|
| Leasehold Improvements | 0.12 | 0.12 | 0.12 | 0.01 | - | Upgrade
|
Updated Nov 14, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.